Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019.
Alexander R ZheutlinCatherine G DeringtonJennifer S HerrickRobert S RosensonBharat PoudelMonika M SaffordTodd M BrownElizabeth A JacksonMark WoodwardStephanie ReadingKate OrrothJason ExterSalim S ViraniPaul MuntnerAdam P BressPublished in: Circulation. Cardiovascular quality and outcomes (2022)
Less than half of veterans received LLT intensification in the year after MI or coronary revascularization suggesting a missed opportunity to reduce atherosclerotic cardiovascular disease risk.
Keyphrases
- coronary artery disease
- cardiovascular disease
- coronary artery
- coronary artery bypass grafting
- percutaneous coronary intervention
- heart failure
- left ventricular
- type diabetes
- aortic stenosis
- cardiovascular events
- metabolic syndrome
- atrial fibrillation
- cardiovascular risk factors
- mesenchymal stem cells
- cell therapy
- aortic valve
- transcatheter aortic valve replacement